Behavioral
Mass General Brigham Community Physicians INC.
Mass General Brigham Community Physicians INC. was paid $33.80M by Medicaid between Jan 2018 and Dec 2024, across 303 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 24% of everything it billed.
33Billing provider infoMASS GENERAL BRIGHAM COMMUNITY PHYSICIANS INC.
HAVERHILL, MA 01830
HAVERHILL, MA 01830
33aNPI1891112637assigned 03/18/2014
33bProvider typeMental Health Counselor
28Total paid$33.80M
24GClaims1,190,571
24DCodes billed303
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Mental Health Counselor providers in Massachusetts
Rank by total paid#6 of 597
Median peer was paid$53K
This provider vs. median633×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 182,900 | $4.90M | |
| 2019 | 160,046 | $4.65M | |
| 2020 | 150,471 | $4.51M | |
| 2021 | 187,160 | $5.89M | |
| 2022 | 222,670 | $7.28M | |
| 2023 | 166,283 | $4.06M | |
| 2024incomplete | 121,041 | $2.52M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 167,987 | 161,141 | $8.12M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 165,758 | 159,483 | $7.12M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.3% | 43,098 | 41,521 | $2.15M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.5% | 20,858 | 20,309 | $1.51M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.6% | 13,148 | 13,024 | $876K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.5% | 22,290 | 21,155 | $854K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.4% | 12,530 | 12,407 | $827K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.1% | 10,298 | 9,863 | $698K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.0% | 50,517 | 49,946 | $687K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.0% | 7,597 | 7,556 | $677K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.9% | 22,375 | 22,116 | $633K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 8,447 | 8,367 | $540K |
291 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.5% | 7,609 | $521K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.4% | 46,392 | $467K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.3% | 7,777 | $429K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.2% | 15,133 | $406K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 1.1% | 42,821 | $373K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,880 | $303K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 4,734 | $262K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 2,003 | $260K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 16,815 | $256K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 4,318 | $244K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 3,210 | $233K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 21,871 | $230K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 7,734 | $225K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,733 | $213K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 1,185 | $175K |
| J0897 | Injection, denosumab, 1 mg | <1% | 518 | $175K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 5,420 | $163K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 18,850 | $147K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 1,163 | $143K |
| 80050 | General health panel | <1% | 8,476 | $141K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,291 | $128K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 5,869 | $127K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,662 | $120K |
| 82728 | <1% | 8,206 | $101K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,451 | $93K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,083 | $93K |
| 95117 | <1% | 12,208 | $91K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 712 | $84K |
| 99173 | <1% | 6,380 | $82K | |
| 85027 | <1% | 13,074 | $77K | |
| 86803 | <1% | 6,099 | $76K | |
| 82607 | <1% | 5,484 | $75K | |
| ATP17 | <1% | 6,666 | $73K | |
| ATP14 | <1% | 6,749 | $72K | |
| 87634 | <1% | 1,157 | $65K | |
| 90756 | <1% | 3,443 | $65K | |
| 88312 | <1% | 1,122 | $61K | |
| 93000 | <1% | 7,597 | $55K | |
| 83550 | <1% | 6,936 | $55K | |
| 84439 | <1% | 6,565 | $54K | |
| 92587 | <1% | 5,589 | $48K | |
| ATP03 | <1% | 6,975 | $47K | |
| 99423 | <1% | 53 | $45K | |
| 83970 | <1% | 1,329 | $44K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 1,440 | $43K |
| 99223 | Prolong inpt eval add15 m | <1% | 644 | $40K |
| 90837 | Psychotherapy session, about an hour | <1% | 367 | $38K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 373 | $37K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,962 | $33K |
| ATP08 | <1% | 3,740 | $32K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 619 | $32K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,893 | $32K |
| 92551 | <1% | 3,310 | $32K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,482 | $32K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,867 | $30K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 570 | $30K |
| 83721 | <1% | 3,346 | $28K | |
| 92558 | <1% | 2,212 | $27K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 1,297 | $27K |
| 84146 | <1% | 1,492 | $26K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,669 | $26K |
| 84153 | <1% | 1,549 | $26K | |
| 0001A | <1% | 583 | $26K | |
| 0002A | <1% | 554 | $25K | |
| 87340 | <1% | 2,662 | $25K | |
| 87081 | <1% | 3,799 | $25K | |
| 92552 | <1% | 948 | $23K | |
| 97802 | <1% | 269 | $23K | |
| 90961 | <1% | 492 | $22K | |
| 95115 | <1% | 3,252 | $22K | |
| 96127 | <1% | 4,313 | $21K | |
| 81001 | <1% | 7,168 | $21K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 567 | $21K |
| 82746 | <1% | 1,540 | $21K | |
| 94760 | <1% | 9,963 | $21K | |
| ATP15 | <1% | 1,891 | $20K | |
| 82043 | <1% | 4,175 | $20K | |
| 82570 | <1% | 4,480 | $20K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 329 | $20K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,281 | $19K |
| 83540 | <1% | 3,158 | $19K | |
| 93015 | <1% | 535 | $19K | |
| 76536 | <1% | 511 | $19K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 584 | $19K |
| 83001 | <1% | 1,076 | $18K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 216 | $18K |
| 84702 | <1% | 1,165 | $16K | |
| 99051 | <1% | 1,024 | $16K | |
| 91320 | <1% | 281 | $16K | |
| 80061 | Lipid panel | <1% | 21,535 | $15K |
| ATP18 | <1% | 1,395 | $15K | |
| 20610 | <1% | 620 | $15K | |
| 94060 | <1% | 780 | $15K | |
| 84480 | <1% | 1,117 | $14K | |
| 95811 | <1% | 312 | $14K | |
| 99188 | <1% | 543 | $14K | |
| 0071A | <1% | 287 | $13K | |
| 83735 | <1% | 2,238 | $13K | |
| 83002 | <1% | 779 | $13K | |
| 94729 | <1% | 716 | $13K | |
| 90674 | <1% | 782 | $13K | |
| 97803 | <1% | 281 | $12K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 3,958 | $12K |
| 90962 | <1% | 226 | $12K | |
| 90480 | <1% | 417 | $12K | |
| 83718 | <1% | 1,583 | $12K | |
| 81025 | <1% | 1,880 | $12K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 1,113 | $12K |
| 86706 | <1% | 1,175 | $12K | |
| 94726 | <1% | 681 | $11K | |
| 86140 | <1% | 2,374 | $11K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 417 | $11K |
| 90677 | <1% | 79 | $11K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 93 | $10K |
| 0124A | <1% | 354 | $10K | |
| 96401 | <1% | 218 | $10K | |
| 73562 | <1% | 656 | $10K | |
| 0072A | <1% | 209 | $9K | |
| 85610 | <1% | 2,773 | $9K | |
| 95251 | <1% | 832 | $9K | |
| 87807 | <1% | 843 | $9K | |
| 84703 | <1% | 1,332 | $9K | |
| 90474 | <1% | 674 | $9K | |
| 87210 | <1% | 1,935 | $9K | |
| 99205 | Prolong outpt/office vis | <1% | 114 | $8K |
| 73130 | <1% | 613 | $8K | |
| 85652 | <1% | 3,425 | $8K | |
| 86376 | <1% | 617 | $8K | |
| ATP07 | <1% | 959 | $8K | |
| 76830 | Ultrasound, transvaginal | <1% | 140 | $8K |
| 0004A | <1% | 191 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,124 | $7K |
| 99443 | <1% | 678 | $7K | |
| ATP11 | <1% | 790 | $7K | |
| 73030 | <1% | 607 | $7K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 1,088 | $7K |
| 71271 | <1% | 165 | $7K | |
| 94010 | <1% | 458 | $7K | |
| 93296 | <1% | 771 | $7K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 137 | $7K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 34 | $7K |
| 86704 | <1% | 571 | $6K | |
| 99386 | <1% | 51 | $6K | |
| 90661 | <1% | 239 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 516 | $6K |
| 86141 | <1% | 466 | $6K | |
| 99397 | <1% | 59 | $6K | |
| 76770 | <1% | 169 | $6K | |
| 85014 | <1% | 2,498 | $5K | |
| 99385 | <1% | 53 | $5K | |
| 82627 | <1% | 267 | $5K | |
| 73110 | <1% | 360 | $5K | |
| 90732 | <1% | 62 | $5K | |
| 93295 | <1% | 271 | $5K | |
| 81002 | <1% | 2,272 | $5K | |
| 90691 | <1% | 61 | $5K | |
| 86430 | <1% | 911 | $5K | |
| 99442 | <1% | 566 | $5K | |
| 95024 | <1% | 63 | $5K | |
| 20611 | <1% | 92 | $4K | |
| ATP10 | <1% | 480 | $4K | |
| 82465 | <1% | 1,853 | $4K | |
| 85007 | <1% | 1,290 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,473 | $4K |
| 85730 | <1% | 691 | $4K | |
| 81003 | <1% | 1,807 | $4K | |
| 83690 | <1% | 577 | $4K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,188 | $3K |
| 93880 | <1% | 58 | $3K | |
| 90750 | <1% | 35 | $3K | |
| 99381 | <1% | 37 | $3K | |
| 99406 | <1% | 1,192 | $3K | |
| 88313 | <1% | 63 | $3K | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,838 | $3K |
| ATP06 | <1% | 384 | $3K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 25 | $3K |
| 82533 | <1% | 211 | $3K | |
| 99221 | <1% | 82 | $3K | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 165 | $3K |
| 90662 | <1% | 402 | $3K | |
| 85651 | <1% | 797 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 27 | $3K |
| 93297 | <1% | 275 | $3K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 169 | $3K |
| 99177 | <1% | 698 | $2K | |
| 73630 | <1% | 190 | $2K | |
| 82947 | <1% | 1,789 | $2K | |
| 72100 | <1% | 149 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 25 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 16,025 | $2K |
| 86762 | <1% | 150 | $2K | |
| 91065 | <1% | 68 | $2K | |
| 86800 | <1% | 133 | $2K | |
| 11900 | <1% | 53 | $2K | |
| ATP05 | <1% | 227 | $2K | |
| 73610 | <1% | 110 | $2K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 179 | $2K |
| 93793 | <1% | 302 | $1K | |
| ATP04 | <1% | 211 | $1K | |
| 82962 | <1% | 2,891 | $1K | |
| 94727 | <1% | 135 | $1K | |
| 86308 | <1% | 289 | $1K | |
| 82784 | <1% | 196 | $1K | |
| ATP02 | <1% | 233 | $1K | |
| 93018 | <1% | 181 | $1K | |
| 77080 | <1% | 117 | $1K | |
| 90715 | <1% | 97 | $1K | |
| 73502 | <1% | 59 | $1K | |
| 82150 | <1% | 163 | $985.99 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,449 | $972.21 |
| 71250 | <1% | 33 | $925.12 | |
| 90686 | <1% | 18,579 | $913.01 | |
| 90620 | <1% | 97 | $876.41 | |
| 94200 | <1% | 104 | $833.44 | |
| 85018 | <1% | 331 | $807.88 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $803.09 |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 12 | $741.95 |
| 80074 | <1% | 17 | $714.17 | |
| 11200 | <1% | 12 | $692.34 | |
| 84550 | <1% | 905 | $655.01 | |
| 73140 | <1% | 36 | $649.09 | |
| 93294 | <1% | 80 | $608.73 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 25 | $586.88 |
| 90651 | <1% | 667 | $581.72 | |
| 82948 | <1% | 418 | $565.94 | |
| 0052A | <1% | 12 | $550.44 | |
| 98926 | <1% | 17 | $490.60 | |
| 0054A | <1% | 15 | $452.83 | |
| 99441 | <1% | 37 | $414.15 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 63 | $404.04 |
| 93227 | <1% | 25 | $353.97 | |
| 94375 | <1% | 22 | $328.39 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 114 | $309.52 |
| 80076 | <1% | 4,234 | $306.10 | |
| 93016 | <1% | 24 | $264.14 | |
| 98968 | <1% | 47 | $262.63 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 336 | $252.64 |
| 86708 | <1% | 24 | $251.06 | |
| 84436 | <1% | 40 | $237.27 | |
| 82248 | <1% | 927 | $231.41 | |
| 84144 | <1% | 12 | $228.36 | |
| 99493 | <1% | 12 | $214.46 | |
| 90670 | <1% | 5,206 | $211.90 | |
| 82550 | <1% | 156 | $196.90 | |
| 90658 | <1% | 14 | $179.87 | |
| 84100 | <1% | 426 | $176.01 | |
| 86765 | <1% | 12 | $159.48 | |
| 73080 | <1% | 15 | $143.36 | |
| ATP13 | <1% | 13 | $141.57 | |
| 29530 | <1% | 12 | $134.69 | |
| 84460 | <1% | 1,775 | $123.17 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 76 | $118.44 |
| 36415 | Collection of venous blood by venipuncture | <1% | 27,565 | $115.78 |
| 83014 | <1% | 13 | $108.54 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 42 | $94.20 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 76 | $94.11 |
| 82977 | <1% | 65 | $85.38 | |
| 91312 | <1% | 321 | $75.01 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 45 | $65.04 |
| Q4010 | Cast supplies, short arm cast, adult (11 years +), fiberglass | <1% | 25 | $56.90 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 186 | $56.27 |
| 93270 | <1% | 12 | $52.99 | |
| 82247 | <1% | 78 | $49.00 | |
| 87220 | <1% | 12 | $45.24 | |
| 84450 | <1% | 1,712 | $44.76 | |
| 82270 | <1% | 12 | $39.59 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 29 | $28.21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $20.28 |
| 90734 | <1% | 374 | $16.58 | |
| Q4022 | Cast supplies, short arm splint, adult (11 years +), fiberglass | <1% | 13 | $15.39 |
| 96160 | <1% | 177 | $6.20 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 12 | $1.36 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 84 | $0.24 |
| Q0247 | Injection, sotrovimab, 500 mg | <1% | 36 | $0.08 |
| 90698 | 0% | 3,651 | $0.00 | |
| 90696 | 0% | 52 | $0.00 | |
| 80069 | 0% | 38 | $0.00 | |
| 90697 | 0% | 214 | $0.00 | |
| 91307 | 0% | 797 | $0.00 | |
| 90744 | 0% | 602 | $0.00 | |
| 91305 | 0% | 171 | $0.00 | |
| 71045 | Radiologic examination, chest; single view | 0% | 26 | $0.00 |
| 90716 | 0% | 51 | $0.00 | |
| 90688 | 0% | 25 | $0.00 | |
| 90633 | 0% | 1,188 | $0.00 | |
| 91300 | 0% | 1,332 | $0.00 | |
| 90710 | 0% | 26 | $0.00 | |
| 90681 | 0% | 519 | $0.00 | |
| 90685 | 0% | 128 | $0.00 | |
| 90707 | 0% | 46 | $0.00 | |
| 91308 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTOFER, LYNN (PRESIDENT & COO)
| Provider | Location | Paid |
|---|---|---|
| Mass General Brigham Community Physicians INC | Haverhill, MA | $1.44M |
| Mass General Brigham Community Physicians INC | Medford, MA | $1.41M |
| Mass General Brigham Community Physicians INC. | Westwood, MA | $160K |
| Mass General Brigham Community Physicians INC. | Burlington, MA | $37K |
| Mass General Brigham Community Physicians INC. | Melrose, MA | $14K |
| Mass General Brigham Community Physicians INC. | Westford, MA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.